Our Team

At Anthos Therapeutics, our team is passionately focused on achieving our mission: the development and commercialization of genetically and pharmacologically validated innovative therapies for high-risk cardiovascular and metabolic disease patient populations.

Our Team

At Anthos Therapeutics, our team is passionately focused on achieving our mission: the development and commercialization of genetically and pharmacologically validated innovative therapies for high-risk cardiovascular and metabolic disease patient populations.

Anthos Therapeutics is led by a world-class executive team highly experienced in the successful development of therapies for CVM disease.

John Glasspool, a former leader of Novartis’ cardiovascular franchise with 30 years of experience in the biopharmaceutical industry, is CEO of Anthos Therapeutics. Mr. Glasspool served as Global Head of Novartis’ Cardiovascular and Metabolic Diseases franchise.

Management Team

Dan Bloomfield, M.D, Chief Medical Officer
Dan Bloomfield, M.D
Chief Medical Officer
Mike Doremus, Head of Technical Operations
Mike Doremus
Head of Technical Operations
Debra Freedholm, VP Clinical Operations
Debra Freedholm
VP Clinical Operations
Jonathan Freeman, Ph.D, Co-Founder and Chief Operating Officer
Jonathan Freeman, Ph.D
Co-Founder and Chief Operating Officer
John Glasspool, CEO
John Glasspool
CEO
Lynn Mallett, VP Finance, Human Resources & Corporate Treasurer
Lynn Mallett
VP Finance, Human Resources & Corporate Treasurer
Nik Mehta, Ph.D, Head of Regulatory, Quality and Technical Operations
Nik Mehta, Ph.D
Head of Regulatory, Quality and Technical Operations
Janeen Salter, Director of Clinical Operations
Janeen Salter
Director of Clinical Operations
Jessica Patrick Seabrook, Office Operations & Events Manager
Jessica Patrick Seabrook
Office Operations & Events Manager
Alex Yi, M.D, Ph.D, Senior Director, Medical Affairs
Alex Yi, M.D, Ph.D
Senior Director, Medical Affairs

Consultants

Connie Cullen, PH.D, Founder and Principal, Apollo Biologics
Connie Cullen, PH.D
Founder and Principal, Apollo Biologics
Yasser Khder, Ph.D, Founder & Senior Consultant at MYRA Life Science Services
Yasser Khder, Ph.D
Founder & Senior Consultant at MYRA Life Science Services

Board of Directors

Scott Beardsley,
Scott Beardsley
Ari Brettman, M.D,
Ari Brettman, M.D
Shaun R. Coughlin, M.D, Ph.D,
Shaun R. Coughlin, M.D, Ph.D
Nicholas Galakatos, Ph.D,
Nicholas Galakatos, Ph.D
John Glasspool, CEO
John Glasspool
CEO
Greg Norden,
Greg Norden
Paris Panayiotopoulos,
Paris Panayiotopoulos
Richard Pasternak, M.D,
Richard Pasternak, M.D